0000894189-22-004410.txt : 20220621 0000894189-22-004410.hdr.sgml : 20220621 20220621115813 ACCESSION NUMBER: 0000894189-22-004410 CONFORMED SUBMISSION TYPE: 497K PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20220621 DATE AS OF CHANGE: 20220621 EFFECTIVENESS DATE: 20220621 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ETF Managers Trust CENTRAL INDEX KEY: 0001467831 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 497K SEC ACT: 1933 Act SEC FILE NUMBER: 333-182274 FILM NUMBER: 221026876 BUSINESS ADDRESS: STREET 1: 30 MAPLE STREET STREET 2: SUITE 2 CITY: SUMMIT STATE: NJ ZIP: 07901 BUSINESS PHONE: (908) 897-0513 MAIL ADDRESS: STREET 1: 30 MAPLE STREET STREET 2: SUITE 2 CITY: SUMMIT STATE: NJ ZIP: 07901 FORMER COMPANY: FORMER CONFORMED NAME: FactorShares Trust DATE OF NAME CHANGE: 20090929 FORMER COMPANY: FORMER CONFORMED NAME: FactorETF Trust DATE OF NAME CHANGE: 20090707 0001467831 S000051172 ETFMG Alternative Harvest ETF C000161092 ETFMG Alternative Harvest ETF MJ 497K 1 etfmgmjstrategysticker0620.htm SUPPLEMENT Document
Filed pursuant to Rule 497(e) and 497(k)
File Nos. 811-22310; 333-182274
Supplement to the
Summary Prospectus and Prospectus
dated January 31, 2022 as previously supplemented, of the
ETFMG Alternative Harvest ETF (the “Fund”)
June 21, 2022
Effective August 19, 2022, the methodology of the Fund’s Index will change so that the Index will include common stock (or corresponding American Depositary Receipts (“ADRs”) or Global Depositary Receipts (“GDRs”)) of companies across the globe, including U.S. companies, that (i) engage in the cultivation, production, marketing or distribution of cannabis, including industrial hemp; (ii) engage in the production, marketing, transportation or distribution of products containing cannabis, including industrial hemp, for medical or non-medical purposes, including, but not limited to, drugs, supplements, or food products (the companies in categories (i) and (ii) are “Cannabis Companies”); (iii) engage in the creation, marketing, transportation or distribution of prescription drugs, supplements or food products that utilize cannabinoids as an ingredient (“Pharmaceutical Companies”); (iv) trade tobacco or produce tobacco products, such as cigarettes, cigars or electronic cigarettes; (v) produce cigarette and cigar components, such as cigarette paper and filters; (vi) engage in the creation, production and distribution of fertilizers, plant foods, pesticides or growing equipment to be used in the cultivation of cannabis or tobacco; or (vii) provide other products or services designed for, or used by, companies in the Cannabis industry, including technology, real estate or financial services.
The Fund will only directly invest in companies that are engaged exclusively in legal activities under applicable national and local laws, including U.S. federal and state laws. The Fund may also invest in other investment companies that principally invest, either directly or through derivatives, in component securities of the Index. The Fund may invest a significant portion of its assets in exchange-traded funds (“ETFs”) that invest substantially all of their assets in equity securities of component securities of the Index and derivatives or other instruments that have economic characteristics similar to such securities. While the Fund does not intend to directly invest in swaps, certain ETFs in which the Fund invests may utilize total return swaps to obtain exposure to the price movements of securities of Index component companies without owning or taking physical custody of such security.
Once the changes to the Index become effective, an updated prospectus reflecting these changes will be mailed to shareholders of the Fund. The updated prospectus will include additional information about the changes to the Index and associated risks. Please read the prospectus carefully.
Capitalized terms used herein but not defined shall have the meanings assigned to them in the Summary Prospectus and/or Prospectus.


Please retain this Supplement with your Summary Prospectus and Prospectus for future reference.